Treatment of childhood asthma: weighing available modalities
More details
Hide details
Pneumon 2004;17(3):251-257
New treatment modalities have emerged since the introduction of inhaled drugs for the treatment of childhood asthma. Theophylline preparations are practically no longer used for asthma exacerbations, as inhaled β2-agonists and ipratropium bromide are sufficient for bronchospasm relief. Many long-term studies have established the effectiveness and safety of inhaled steroids, which henceforth replaced sodium chromoglycate, a widely used prophylactic drug. Leukotriene receptor antagonists and long acting β2-agonists are appropriate add-on treatment for those children not responding to steroid monotherapy. Patient compliance, as well as inhalation technique should always be checked before stepping up to more intensive treatment. Pneumon 2004, 17(3):251-257.
Journals System - logo
Scroll to top